Skip to Main Content
U.S. Forest Service
Caring for the land and serving people

United States Department of Agriculture

Home > Search > Publication Information

  1. Share via EmailShare on FacebookShare on LinkedInShare on Twitter
    Dislike this pubLike this pub
    Author(s): A. Dan Wilson; A.C. Doty; L.B. Forse; T.S. Risch
    Date: 2020
    Source: Conference paper (Abstract)
    Publication Series: Scientific Journal (JRNL)
    Station: Southern Research Station
    PDF: Download Publication  (95.0 KB)


    Further investigations of new, noninvasive electronic methods for early White-Nose Syndrome (WNS)-disease diagnosis, based on e-nose VOC-detection of the disease itself, have provided new chemical evidence of metabolic differences in WNS-susceptible bat species. Development of improved methods for pre-symptomatic detection of WNS in bats using the portable C-320 electronic-nose (e-nose) has required multi-phase efficacy studies of instrument capabilities to discriminate between major sources of volatile organic compounds (VOCs) derived from clinical samples. In this phase-2 study, we further tested this e-nose for capabilities to discriminate between bat species based on differences in whole-body VOC emissions. Physiologically active (non-torpid) healthy individuals of nine bat species were temporarily captured outside of caves in Arkansas and Louisiana. VOC emissions from bats were collected using newly developed portable air-collection and sampling-chamber devices in tandem. Sensor-array output responses to bat VOC emissions were compared to those of 22 pure VOC analytical standards from five chemical classes. Distinct smellprint signatures were produced from e-nose analyses of VOC metabolites derived from individual bat species. Smellprint patterns were analyzed using 2-dimensional and 3-dimensional Principal Component Analysis (PCA) to produce aroma map plots showing effective discrimination between bat species with high statistical significance. These results demonstrate potential instrument efficacy for distinguishing between species-specific, bat-derived VOC metabolite emissions as major components of clinical samples collected in caves for disease detection prior to symptom development. This study provided additional information required to fully test the efficacy of a portable e-nose instrument for diagnostic applications in subsequent phase-3 testing of noninvasive, early WNS disease detection in intra-cave hibernating bats. These results suggest a new, possibly more reliable means and improved approach for early WNS-disease detection, based on e-nose VOC-detection capabilities, compared to the more tenuous early-detection capabilities of qPCR based on quantification of Pd-pathogen DNA in swabs from external skin surfaces.

    Publication Notes

    • You may send email to to request a hard copy of this publication.
    • (Please specify exactly which publication you are requesting and your mailing address.)
    • We recommend that you also print this page and attach it to the printout of the article, to retain the full citation information.
    • This article was written and prepared by U.S. Government employees on official time, and is therefore in the public domain.


    Wilson, A. Dan; Doty, A.C.; Forse, L.F.; Risch, T.S. 2020. Phase-2 development of the portable C-320 electronic-nose for noninvasive early detection of White-nose Syndrome in susceptible bat species. Conference paper (Abstract) for 2020 White-nose Syndrome National Webinar, June 10-11, 2020.


    Bat species identification, chiroptera, dermatophytic disease, electronic aroma detection (EAD), e-nose smellprint signatures, insectivorous bats, noninvasive early disease detection, nonnative fungal pathogen, Pseudogymnoascus destructans, VOC emissions, volatile organic compounds, White-nose Syndrome

    Related Search

    XML: View XML
Show More
Show Fewer
Jump to Top of Page